Executive Profile: Pfizer's Geno Germano On Impatience, Innovation And The Influence Of Culture
This article was originally published in Scrip
Geno Germano is group president of Pfizer's Global Innovative Pharma Business, the unit focused on development, registration and commercialization of novel medicines. He is co-chair of the portfolio strategy and investment committee, which aims to maximize the return on R&D investment across the Pfizer portfolio. Germano also manages Pfizer's global health and value function, which works to demonstrate the value of innovation and supports access to Pfizer's medicines. In the latest edition of Scrip's executive profile series, he tells Sukaina Virji of his childhood propensity for hard work, how youthful impatience led him to a successful career in the pharmaceutical industry, and the influence of culture on effectiveness.